Chemical inhibitors of L-amino acid oxidase (LAAO) function through various mechanisms to disrupt the enzyme's catalytic activity. Phenylhydrazine and benzylhydrazine target the enzyme by reacting with the carbonyl group of the substrate-binding site, which is essential for the LAAO catalytic process. By forming a complex with this group, these inhibitors compromise the enzyme's ability to deaminate amino acids, thereby inhibiting its function. Ellman's Reagent operates by a different mechanism, modifying the thiol groups in the active site of LAAO. It forms a disulfide bond with cysteine residues, which is critical for maintaining the enzyme's three-dimensional structure and, hence, its activity. This modification disrupts the tertiary structure necessary for enzymatic activity. Semicarbazide also targets the enzyme by interacting with the aldehyde group of the pyridoxal phosphate (PLP) cofactor, forming a stable semicarbazone complex that prevents PLP from participating in the enzyme's catalytic activity.
Aminooxyacetic acid, gabaculine, and carbidopa inhibit LAAO by targeting the PLP cofactor essential for the enzyme's function. Aminooxyacetic acid and gabaculine bind to PLP, with the latter forming an irreversible bond through its aziridine ring, leading to inactivation of the enzyme. Carbidopa acts as a competitive inhibitor, structurally mimicking the natural substrates of LAAO to obstruct the active site, which precludes amino acid deamination. Hydroxylamine and propargylglycine contribute to inhibition by interfering with the active site and catalytic mechanism of LAAO. Hydroxylamine likely interacts with the cofactor and substrate to form an oxime, disrupting the usual catalysis, while propargylglycine acts as a substrate analogue that irreversibly inactivates the enzyme upon binding. Bathophenanthroline exerts its inhibitory effect by chelating essential ferrous ions, which disrupts the metal ion-dependent catalytic mechanism. In a similar fashion, isatin serves as a competitive inhibitor by occupying the active site, preventing the enzyme from processing its amino acid substrates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Phenylhydrazine | 100-63-0 | sc-250701 sc-250701A | 5 g 100 g | $45.00 $52.00 | ||
Phenylhydrazine inhibits LAAO by reacting with the carbonyl group of the substrate-binding site, which is essential for the catalytic activity of LAAO. This chemical interaction disrupts the enzyme's ability to deaminate amino acids, leading to a decrease in hydrogen peroxide production, a byproduct of LAAO catalysis, thereby inhibiting LAAO function. | ||||||
Hydroxylamine solution | 7803-49-8 | sc-250136 | 100 ml | $72.00 | ||
Hydroxylamine inhibits LAAO by targeting its active site where it likely interacts with the cofactor and substrate, leading to the formation of an oxime and disrupting the normal catalytic cycle of LAAO. This interference with the active site chemistry prevents the enzyme from processing its amino acid substrates. | ||||||
5,5′-Dithio-bis-(2-nitrobenzoic Acid) | 69-78-3 | sc-359842 | 5 g | $80.00 | 3 | |
Ellman's Reagent, also called 5,5'-dithiobis(2-nitrobenzoic acid), can inhibit LAAO by modifying the thiol groups in the enzyme's active site. By forming a disulfide bond with cysteine residues, it can disrupt the tertiary structure necessary for enzymatic activity, thus inhibiting the function of LAAO. | ||||||
Gabaculine | 59556-17-1 | sc-200473 sc-200473A sc-200473B | 10 mg 50 mg 250 mg | $354.00 $884.00 $3069.00 | 5 | |
Gabaculine inhibits LAAO by irreversibly binding to the pyridoxal phosphate (PLP) cofactor through its highly reactive three-membered aziridine ring. This interaction leads to the inactivation of the PLP-dependent enzyme activity, thereby inhibiting the function of LAAO. | ||||||